Rothlin Is Appointed McConnell Duberg Professor
Carla Vanina Rothlin, PhD, newly named as Dorys McConnell Duberg Professor of Immunobiology, studies the mechanisms that regulate the magnitude and resolution of the immune response. Rothlin is also a professor of pharmacology, a member of the Yale Cancer Center, and a Howard Hughes Faculty Scholar.
Yale Pathology Diagnostic Pathology CME Annual Review Scheduled for September 17-18 at Yale Club of NYC
The Yale Department of Pathology presents its inaugural Diagnostic Pathology CME Annual Review on September 17-18 at the Yale Club of New York City. This inaugural course at the Yale Club in the heart of Midtown Manhattan will focus on the recent World Health Organization updates in all major pathology subspecialties.
Yale Study Identifies Causes of Cancers
A team of Yale-led researchers can now quantify the factors causing changes in the DNA that contribute most to cancer growth in tumors of most major tumor types. Their molecular analysis approach brings clarity to a longstanding debate over how much control humans have over developing cancer over time.
American Society for Investigative Pathology to Honor Qin Yan, PhD, with 2023 Outstanding Investigator Award
The American Society for Investigative Pathology has announced it will honor Qin Yan, PhD, Associate Professor of Pathology at Yale School of Medicine, with its 2023 Outstanding Investigator Award.
Manju Prasad, MD, MBBS, on Head and Neck Cancer Awareness Month
In recognition of Head and Neck Cancer Awareness Month, Manju Prasad, MD, MBBS, Professor of Pathology; Director, Endocrine Head and Neck Pathology Fellowship Program; Director, Endocrine Head and Neck Pathology, provides her insight.
Three Yale Cancer Center Trainees Receive Travel Awards to AACR Annual Meeting
The American Association for Cancer Research recently announced awards to support three young scientists from Yale Cancer Center to attend the 2022 Annual Meeting of the American Association for Cancer Research (AACR) in New Orleans from April 8 to 13.
Yale Pathologists Participating in Annual USCAP Meeting to Share Research, Advancements
Pathologists and research scientists from Department of Pathology at Yale School of Medicine will be involved in more than 40 presentations and sessions at the United States and Canadian Academy of Pathology (USCAP) 2022 Annual Meeting in Los Angeles March 19-24.
Irwin receives $7 million grant to investigate healthy interventions for ovarian cancer patients
Yale School of Public Health Associate Dean of Research and Susan Dwight Bliss Professor of Epidemiology Melinda Irwin, Ph.D., M.P.H., has been awarded a five-year, $7 million grant from the National Cancer Institute to explore how nutrition and exercise interventions can improve chemotherapy outcomes and reduce toxicity for women with ovarian cancer.
New Class of Oncogenic Fusions Revealed in Lung and Pancreatic Cancer
A Yale Cancer Center research team has identified novel oncogenic gene fusions in lung and pancreatic cancer, as well as sarcoma. The fusions involve RASGRF1 (an activator of RAS signaling) and promote cellular changes leading to tumor development. The research is described online ahead of print in Clinical Cancer Research.
Adebowale Adeniran, MD, on Kidney Cancer Awareness Month
In recognition of Kidney Cancer Awareness Month, Adebowale Adeniran, MD, Professor of Pathology; Director of Cytopathology; Director, Cytology Laboratory; Director, Anatomic Pathology Elective Program in Pathology, explains how Yale Pathologists work with Smilow Cancer Hospital oncologists to enhance patient care and provide the best course of treatment.
Joanna Gibson, MD, PhD, on Colorectal Cancer Awareness Month
In recognition of Colorectal Cancer Awareness Month, Joanna Gibson, MD, PhD, Associate Professor of Pathology and Director of Quality and Patient Safety at Yale Pathology, explains how Yale Pathologists collaborate with Smilow Cancer Hospital oncologists to determine the best therapeutic course for patients.
Dr. Aileen Fernandez Discusses Diversity Equity, and Inclusion with Shirley Malcolm of the American Association for the Advancement of Science
Aileen Fernandez, PhD, a Postdoctoral Fellow in the Department of Pathology at Yale School of Medicine, speaks with Shirley Malcolm, PhD, Senior Advisor to the Director of the American Association for the Advancement of Science and Director of its SEA Change initiative, which aims to advance institutional transformation in support of diversity, equity and inclusion, especially in colleges and universities.Source: YouTube
Yale New Haven Health Among Medical Centers Reporting Progress on Digital Pathology Implementations
The field of digital pathology is gaining momentum as more health systems, including Yale New Haven Health and WVU Medicine in West Virginia, announce plans for implementation on a large scale.Source: Healthcare Innovation Group
Can Cancer Patients Get Approved COVID Therapies?
In mid-November, Kevin Billingsley, MD, MBA, chief medical officer at Yale Cancer Center, New Haven, Conn., was keeping a close eye on the new COVID variant sweeping across South Africa. Six weeks later, the Omicron variant had become the dominant strain in the U.S. – and the Yale health system was no exception.Source: MD Edge